GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » Return-on-Tangible-Asset

Alpha Tau Medical (Alpha Tau Medical) Return-on-Tangible-Asset : -27.52% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Alpha Tau Medical's annualized Net Income for the quarter that ended in Dec. 2023 was $-29.46 Mil. Alpha Tau Medical's average total tangible assets for the quarter that ended in Dec. 2023 was $107.06 Mil. Therefore, Alpha Tau Medical's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was -27.52%.

The historical rank and industry rank for Alpha Tau Medical's Return-on-Tangible-Asset or its related term are showing as below:

DRTS' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -57.29   Med: -26.51   Max: -21.01
Current: -25.96

During the past 5 years, Alpha Tau Medical's highest Return-on-Tangible-Asset was -21.01%. The lowest was -57.29%. And the median was -26.51%.

DRTS's Return-on-Tangible-Asset is ranked better than
61.61% of 1555 companies
in the Biotechnology industry
Industry Median: -39.47 vs DRTS: -25.96

Alpha Tau Medical Return-on-Tangible-Asset Historical Data

The historical data trend for Alpha Tau Medical's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical Return-on-Tangible-Asset Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
-26.51 -21.01 -57.29 -41.59 -25.63

Alpha Tau Medical Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.34 -27.73 -30.60 -18.03 -27.52

Competitive Comparison of Alpha Tau Medical's Return-on-Tangible-Asset

For the Biotechnology subindustry, Alpha Tau Medical's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's Return-on-Tangible-Asset falls into.



Alpha Tau Medical Return-on-Tangible-Asset Calculation

Alpha Tau Medical's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-29.157/( (120.149+107.388)/ 2 )
=-29.157/113.7685
=-25.63 %

Alpha Tau Medical's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-29.46/( (106.739+107.388)/ 2 )
=-29.46/107.0635
=-27.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data.


Alpha Tau Medical  (NAS:DRTS) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Alpha Tau Medical Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Tau Medical (Alpha Tau Medical) Business Description

Traded in Other Exchanges
N/A
Address
5 Kiryat Hamada Street, Building B3, 4th Floor, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.

Alpha Tau Medical (Alpha Tau Medical) Headlines

From GuruFocus

Alpha Tau Medical to Participate in June Investor Conferences

By sperokesalga sperokesalga 05-24-2023